Protective Effect of ECQ on Rat Reflux Esophagitis Model

• Published in: The Korean journal of physiology & pharmacology Vol. 16; no. 6; pp. 455 - 462
• Main Authors: Jang, Hyeon-Soon, Han, Jeong Hoon, Jeong, Jun Yeong, Sohn, Uy Dong
• Format: Journal Article
• Language: Korean
• Published: 대한생리학회-대한약리학회 01.01.2012; The Korean Journal of Physiology & Pharmacology Editorial Office
• Subjects: Rats; Extracts; Antioxidant; Rumex Aquaticus Herba; Reflux esophagitis
• ISSN: 1226-4512; 2093-3827

This study was designed to determine the protective effect of Rumex Aquaticus Herba extracts containing quercetin-3-${\beta}$ -D-glucuronopyranoside (ECQ) on experimental reflux esophagitis. Reflux esophagitis was induced by surgical procedure. The rats were divided into seven groups, namely normal group, control group, ECQ (1, 3, 10, 30 mg/kg) group and omeprazole (30 mg/kg) group. ECQ and omeprazole groups received intraduodenal administration. The Rats were starved for 24 hours before the experiments, but were freely allowed to drink water. ECQ group attenuated the gross esophagitis significantly compared to that treated with omeprazole in a dose-dependent manner. ECQ decreased the volume of gastric juice and increased the gastric pH, which are similar to those of omeprazole group. In addition, ECQ inhibited the acid output effectively in reflux esophagitis. Significantly increased amounts of malondialdehyde (MDA), myeloperoxidase (MPO) activity and the mucosal depletion of reduced glutathione (GSH) were observed in the reflux esophagitis. ECQ administration attenuated the decrement of the GSH levels and affected the MDA levels and MPO activity. These results suggest that the ECQ has a protective effect which may be attributed to its multiple effects including anti-secretory, anti-oxidative and anti-inflammatory actions on reflux esophagitis in rats.